🐝 Bee Products Against Cutaneous Fungal Infections: What Does the Research Say?
The Problem: Cutaneous Fungi (Dermatophytes) Dermatophytosis (Tinea / Ringworm) is an infection of the keratinized tissues of the skin, hair, or nails. It is predominantly caused by dermatophyte fungi of the genera Trichophyton and Microsporum.
Clinical Manifestations: Red macules, pruritus, scaling, hair breakage, and alopecia in affected areas. Transmission occurs via direct contact with fungal spores, and prevalence increases under immunocompromised conditions.
Conventional Treatment Standard therapy includes topical antifungal creams and shampoos, and occasionally systemic agents such as azoles (e.g., fluconazole) or allylamines (e.g., terbinafine). Challenges include prolonged treatment durations (weeks to months) and emerging dermatophyte resistance, underscoring the need for novel therapeutic strategies.
Bee Venom: An Innovative Research Avenue
Honeybee venom contains peptides (melittin, apamin, adolapin), enzymes (phospholipase A₂, hyaluronidase), and other bioactive compounds. Beyond eliciting local pain, it exhibits antimicrobial properties.
Research Findings:
• Trichophyton rubrum / T. mentagrophytes• Annals of Dermatology (2018): Whole bee venom significantly inhibited T. rubrum growth, whereas isolated melittin/apamin were ineffective, suggesting a synergistic interaction among venom components.
• J. Appl. Biol. Chem (2012): Near-complete inhibition of T. mentagrophytes at low venom concentrations, sometimes outperforming fluconazole.
• Microsporum canis (Onderstepoort J. Vet. Res., 2024): Fluconazole-resistant strains remained sensitive to venom, though at higher concentrations; local applications were proposed for further investigation.
Mechanism of Action: Melittin disrupts fungal cell membranes by pore formation and induces oxidative damage; venom enzymes enhance tissue permeability and potentiate antifungal effects.
Implications: Promising in vitro results, but no clinical trials in humans have yet been conducted.
Propolis: “The Hive’s Antibiotic”
Propolis is a resinous mixture processed by bees from plant sources, exhibiting antibacterial and antifungal activity.
Key Studies:
• J Contemp Med Sci (2015): Propolis extracts inhibited growth of Trichophyton and Microsporum, occasionally showing activity comparable to conventional antifungals.
• Clinical Report (2012): Brazilian green propolis extract supported treatment of tinea pedis and tinea corporis.
• Novel Formulations: A 16% propolis gel reduced dermatophyte viability, proposed as a topical therapeutic candidate.
Consideration: Efficacy varies with botanical origin, highlighting the need for standardized extracts in research.
Medical Honey
Honey is renowned for its antibacterial properties and also exhibits antifungal activity.
• Jarrah honey: In vitro inhibition of dermatophytes at 40% concentrations.
• Manuka / Tea Tree honey: Demonstrated suppression of various dermatophyte strains.
• Mechanism: Honey creates a hyperosmotic environment unfavorable to fungi and contains enzymes and phenolic compounds detrimental to pathogens.
Royal Jelly
Studies have shown antifungal activity against Candida albicans. Direct evidence against dermatophytes is lacking, but bioactive constituents may exert effects in cutaneous fungal infections.
Bee Pollen
Recent reviews report antimicrobial, including antifungal, activity. Evidence specifically targeting dermatophytes remains preliminary and requires further study.
Ethnobotanical and Anecdotal Evidence
• Traditional medicine in China and Korea: Bee venom and propolis used for dermatological conditions.
• Contemporary anecdotes: Patients report improvements in cutaneous fungal infections with cosmetic formulations containing bee venom or propolis, although clinical validation is lacking.
• Marketed products: Creams and serums containing bee venom or propolis exist, but no controlled clinical trials confirm efficacy against dermatophytes.
Safety Considerations
• Allergies: Bee venom may rarely induce anaphylaxis; propolis can trigger contact allergy.
• Testing: Skin sensitivity testing is essential prior to bee venom application.
• Drug Interactions: Avoid combining with immunosuppressive therapies such as biologics or corticosteroids.
• Conventional Treatment: Antifungal drugs remain first-line therapy; bee products are a promising complementary avenue, not a replacement.
Conclusion
Bee products—primarily bee venom and propolis, but also medical honey, royal jelly, and bee pollen—demonstrate significant antifungal potential against dermatophytes.
• In vitro: Clear inhibition of Trichophyton and Microsporum.
• Clinical practice: Positive anecdotal evidence exists, but large-scale human trials are lacking.
• Future directions: Development of bee-derived pharmaceuticals for resistant dermatophytosis is plausible.
Until then, integrating scientific knowledge with clinical caution is essential, considering bee products as a supplementary, research-driven strategy to expand dermatological therapeutic options.
© 2026 איגוד אפיתרפיה ישראל וכותבי המאמרים. כל הזכויות שמורות. מותר לצטט קטעים קצרים בציון המקור וקישור למאמר.